Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-039953
Filing Date
2021-06-11
Accepted
2021-06-11 17:35:16
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3935
  Complete submission text file 0001209191-21-039953.txt   5356
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STRATA SKIN SCIENCES, INC. 5 WALNUT GROVE DRIVE SUITE 140 HORSHAM PA 19044
Business Address
Humphries William D. (Reporting) CIK: 0001674278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 211012457